Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio

By Rinaki Eleni   Valsami Georgia   Macheras Panos  

Pharmaceutical Research, Vol. 20, Iss. 12, 2003-12 ,pp. : 1917-1925

Springer Publishing Company

Access to resources Recommend Favorite

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

By Wu Chi-Yuan   Benet Leslie Z.  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 11-23

Springer Publishing Company

Access to resources Recommend Favorite

The biopharmaceutics classification system (BCS): Class III drugs - better candidates for BA/BE waiver?

By Blume H.H.   Schug B.S.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 2, 1999-12 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

By Lobenberg R.   Amidon G.L.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 3-12

Elsevier

Access to resources Recommend Favorite

Feasibility of Biowaiver Extension to Biopharmaceutics Classification System Class III Drug Products: Cimetidine

By Jantratid Ekarat   Prakongpan Sompol  

Clinical Pharmacokinetics, Vol. 45, Iss. 4, 2006-01 ,pp. : 385-399

Adis International

Access to resources Recommend Favorite